That's essential, since the method a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work. Simply put, we need to know how these proteins fold if we want a drug to work. Historically, this has been an experimental procedure (the legacy report prediction). But now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was an advancement almost nobody saw. But it's going to have extensive implications for treating disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, naturally, there will be plenty of financial investment opportunities in this area, too. Shifting topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech stock). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it drew back perhaps substantially prior to going greater - longtime readers. I have actually been covering bitcoin for a very long time now. One of the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were primarily informing readers. But that's not the big concern any longer. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So consider that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. jeff brown latest prediction. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are numerous fantastic private companies on the brink of hitting the general public markets And I have actually been dealing with a brand-new method for you to invest even prior to these companies go public.
This chance has been developing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to book your spot for free.
Emma Walsh here, handling editor of the Journal. Routine Journal readers understand that tech isn't our typical beat (jeff brown biotech pick). And when it concerns tech investing, we leave it to the specialists. Luckily, we have several such professionals in our Rolodex. Our coworker Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing professionals we understand (democratic republic). In truth, he had several triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and forecast what's just around the corner.
That includes things like 5G networks, biotech, expert system, and far more. These trends are experiencing exponential growth and producing amazing chances for investors. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see coming in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I've been covering for years now. jeff brown genome sequencing. However despite what many readers might believe, this is a pattern that's simply starting. Even though the COVID-19 pandemic interfered with supply chains in 2015, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by 2 months (artificial intelligence). Losing 2 months of manufacturing and sales really affects the number of 5G devices are offered in the calendar year. When you consider all of that, selling 250 million systems is amazing. More notably, the hold-ups brought on by the pandemic produced a lot of bottled-up need. And that demand is now going to be pressed into 2021. In truth, I predict that more than 500 million 5G gadgets will be shipped in 2021 - jeff brown. And that's not my only 5G forecast When I've discussed 5G in the past, I have actually explained its 3 various phases.
In Stage Two, 5G devices go on sale. 5G phones and other products begin to reach consumers. And in Stage 3, 5G services begin to be offered (future report review). That's when we begin to see applications working on 5G networks. Consider things like huge multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Stage Three by this summer. This begins something of a virtuous cycle: Many people don't actually appreciate the innovation. However they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being established. In fact, 5G is going to open a suite of unbelievable applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these technologies require 5G. The financial investment chances going forward will be massive. Stepping far from 5G, the next essential technology I visualize in 2021 is CRISPR genetic editing. CRISPR stands for "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it's one of the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software.
The program can crash or not operate properly. CRISPR uses a comparable idea but with our genetic code. "Typos" in our genome can lead to disease. CRISPR can fix these "typos." For many years, CRISPR was mainly a specific niche technology that wasn't well comprehended. And throughout that time, there were really just 3 companies running in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're treating diseases and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR business is going public and providing extraordinary returns. This entire market is efficiently a greenfield chance.
There's room for numerous business to exist in this area. jeff brown genetic sequencing stock. And there will be more. That's my prediction for CRISPR in 2021. I predict that two or 3 more hereditary modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things occurring at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can accurately anticipate the folding of a protein based entirely on its amino acid series with 92. 4% precision. That's essential since the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been a trial-and-error procedure. And now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're created to do. And here's my next prediction. I forecast that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however several drug treatments produced using this technology. This was one of those advancements that practically nobody noticed. But it's going to have profound implications for curing disease. And, naturally, there will be plenty of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it pulled back perhaps substantially prior to going higher. I have actually been covering bitcoin for a very long time now. Among the first research study reports I ever published was on bitcoin - what is the legacy report predicting. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time.
However nobody is asking that question any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. jeff bezos. Mass, Mutual is a 150-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the information depends on date since February 2021, but we could not separately verify this claim. Given Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down a precise figure at this moment. Brown is best known for his sage-like capability to select winning technology stocks. He spent more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience provides him an outstanding perspective on the market. He's always on the hunt for new chances, and he shares a lot of his finest picks in the Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding track record as a stock-picker, and he effectively predicted some of the most significant financial occasions of the previous 20 years. Although he doesn't appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. Nobody on Wall Street gets it best each time, but Jeff Brown's accurate forecasts have made him legions of devoted followers. That states a lot about his capability. The Near Future Report is published by Brownstone Research study, a popular monetary research study publisher. Brownstone Research offers numerous research services with a wide range of specializations - black sea.
The business is also connected with Bonner & Partners, another well-respected research study publisher - biotech stocks jeff brown. On its site, Brownstone states its mission is to supply retail investors with professional-grade research study: "For too long, the best investment research study has actually not been offered to private financiers. It has been usually scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown investor prediction. The objective of Brownstone Research is to make that kind of proprietary research study available to any investors looking to get an edge in the markets. The goal is basic to provide distinct and rewarding financial investment research study discovered no place else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise acts as the firm's Chief Financial investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to provide its clients. After years of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout the majority of America. If you understand even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. future report review. Whatever he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge project.
In fact, Brown thinks S.A.V. last week. might be "the biggest pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying two innovative innovations: expert system and electrical vehicles. Musk hopes the mix will assist him develop the first fully-autonomous, self-driving cars ever. It's nothing except the automotive industry's Holy Grail. As you know, electric lorries and self-driving cars and truck stocks have been huge this year, however the Wall Street device has approved buzz without much concrete outcome. In spite of an extreme boost in competitors over the previous few years, Brown still thinks Musk has the finest opportunity of putting everything together.
tech might be the magic string that ties all of it together. S.A.V. means Shared Autonomous Lorry, and it could be the future of transportation. Generally, this technology would allow you to lease your cars and truck as an autonomous, self-driving taxi when you're not using it. You merely get out of the car and press a button on an app that tells the car to "sign up with the fleet." Next thing you know, you're relaxing on your couch while your car shuttles ride-sharers around town. Best of all, you get to keep a hefty piece of the profits. It sounds insane, but it could be closed than you believe.